Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2009
11/25/2009CN101589042A Pharmacologically active n,n'-substituted 3,7-diazabicyclo [3.3.1] nonanes, pharmaceutical compositions based thereon and a method for the use thereof
11/25/2009CN101589041A Nitrogen-containing heterocyclic compounds and methods of use thereof
11/25/2009CN101589036A Aminopyrimidines useful as inhibitors of protein kinases
11/25/2009CN101587199A Fluorinated quinacridone in LCD color filter
11/25/2009CN101585838A Matrine sodium sulfonate and preparation method
11/25/2009CN101585837A Method for separating matrine and oxymatrine from total matrines
11/25/2009CN101585836A Novel method for preparing Nevirapine
11/25/2009CN100562511C 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
11/24/2009US7622584 Low driving voltages, high efficiencies, high luminance, long life-times and low power consumption; compound are anthracenes substituted with imidazo(1,2-a)pyridine ring(s); OLEDS; high electron transport capabilities
11/24/2009US7622583 4-((5-Chloro-3-(4-methyl-3-trifluoromethylbenzenesulfonylamino)pyridin-2-yl)-oxo-)1H-pyrrolo(2,3-)pyridine;interfere with ligand (monocyte chemoatactic protein-1) for chemokine receptors (CCR2); antiinflammatory agents; immunomodulators; bactericides; viricides; fungicides
11/24/2009US7622582 Derivatives of 1-phenyl-benzofuro[3,2]pyridin-2(1H)-one
11/24/2009US7622581 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones useful as anti-infective pharmaceutical agents
11/24/2009US7622482 anticancer agents; tyrosine kinase inhibitors based on pyrazole-3-amine linked through amine to fused heterocyclic ring such as benzimidazole, or imidazo[4,5-b]pyridine; e.g. N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-(1-(4-fluorophenyl)ethyl)-3H-imidazo[4,5-b]pyridin-5-amine
11/24/2009US7622481 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic
11/24/2009US7622480 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents
11/24/2009US7622479 For example, 2-(1,3-benzodioxol-5-yl)-6-phenyl-1H-imidazo[4,5-b]pyridinetyrosine; kinase-inhibiting activity; use in treatment of breast cancer, prostate cancer, lung cancer or pancreatic carcinoma
11/24/2009US7622466 morpholin-4-yl-[5-(3-piperidin-1-yl-propoxy)-1H-pyrrolo[2,3-b]pyridin-2-yl]-methanone; treatment of obesity-related disorders such as diabetes, Syndrome X, or atherosclerotic disease and related disorders such as hypertriglyceridemia and hypercholesteremia
11/24/2009CA2433197C Gyrase inhibitors and uses thereof
11/24/2009CA2385882C Tyrosine derivatives
11/19/2009WO2009140624A2 Glucokinase activators
11/19/2009WO2009140320A1 Pyrrolopyridines as kinase inhibitors
11/19/2009WO2009140128A2 Compounds and compositions as kinase inhibitors
11/19/2009WO2009140101A2 Imidazopyridine compounds useful as mmp-13 inhibitors
11/19/2009WO2009139916A1 Tricyclic triazole compounds that modulate hsp90 activity
11/19/2009WO2009139475A1 Organic electroluminescent device
11/19/2009WO2009139373A1 Amide compound
11/19/2009WO2009139340A1 Pyrazole compound
11/19/2009WO2009139076A1 Lipoprotein lipase-activating compositions comprising benzene derivates
11/19/2009WO2009138792A1 Substituted quinazolines
11/19/2009WO2009138789A1 Substituted quinazolines as blood platelet lowering agents
11/19/2009WO2009138440A1 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs
11/19/2009WO2008145839A8 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
11/19/2009US20090286983 Pyrazolopyridine Derivates
11/19/2009US20090286841 Certain chemical entities, compositions, and methods
11/19/2009US20090286827 Novel bi-aryl amines
11/19/2009US20090286815 Pyrimidine Classical Cannabinoid Compounds and Related Methods of Use
11/19/2009US20090286793 Pde4b inhibitors and uses therefor
11/19/2009US20090286777 5,6,Fused Pyrrolidine Compounds Useful as Tachykinin Receptor Antagonists
11/19/2009US20090286767 Substituted quinolin-4-ylamine analogues
11/19/2009US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009US20090285756 11c/18 f-labeled inhibitors of glycogen synthase kinase-3
11/19/2009DE102008023801A1 Substituierte Imidazo- und Triazolopyrimidine, Imidazo- und Pyrazolopyrazine und Imidazotriazine Substituted imidazo and triazolopyrimidines, imidazo and Pyrazolopyrazine and imidazotriazines
11/19/2009CA2724262A1 Pyrrolopyridines as kinase inhibitors
11/19/2009CA2724215A1 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs
11/19/2009CA2724214A1 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
11/19/2009CA2724213A1 Substituted quinazolines as blood platelet lowering agents
11/19/2009CA2724180A1 Substituted quinazolines
11/19/2009CA2724116A1 Glucokinase activators
11/19/2009CA2724077A1 Amide compound
11/19/2009CA2723455A1 Lipoprotein lipase-activating compositions comprising benzene derivates
11/18/2009EP2119716A1 Aza-bridged-ring compound
11/18/2009EP2118103A2 Azaindole derivatives as cftr modulators
11/18/2009EP2118101A1 Imidazo [1,5-a] pyridine derivatives as inhibitors of glutaminyl cyclase
11/18/2009EP2118100A1 New 3- ([1,2,4] triazolo [4,3-a] pyridin-7-yl)benzamide derivatives
11/18/2009EP2118074A1 Compounds for the prevention and treatment of cardiovascular diseases
11/18/2009EP2118069A2 Bis-aryl amide derivatives useful for the treatment of cancer
11/18/2009EP1934218B1 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
11/18/2009EP1910359B1 PYRIDO [2 , 3-D]PYRIMIDINE-2 , 4-DIAMINE COMPOUNDS AS PTPlB INHIBITORS
11/18/2009EP1817033B1 Treatment of inflammatory bowel disease
11/18/2009EP0892789B2 Irreversible inhibitors of tyrosine kinases
11/18/2009CN101583614A Polycyclic agents for the treatment of respiratory syncytial virus infections
11/18/2009CN101583612A Azetidinone derivatives and methods of use thereof
11/18/2009CN100560585C New benzimidazole derivative
11/17/2009US7619089 Formulations and use of e.g. 2-chloro-N-(8 alpha ,9S)cinchonan-9-yl)-3-trifluoromethyl-benzamide hydrochloride for treating pain, Parkinson's disease, epilepsy, sleep apnea, alcoholism, psychological disorders, migraines
11/17/2009US7619086 HIV integrase inhibitors
11/17/2009US7618982 (R)-6-benzyloxymethyl-2-pyridin-4-yl-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one; cancer and cell proliferation disorders; Cdk2 and Cdc7 inhibiting
11/17/2009US7618981 Imidazopyridinyl-benzamide anti-cancer agents
11/17/2009US7618980 Pyrrolo(oxo)quinolines as 5HT ligands
11/17/2009US7618979 Prostaglandin receptor antagonists; allergic rhinitis, nasal congestion and asthma; [5-[(4-chlorophenyl)thio]-4-(methylsulfonyl)-6,7,8,9-tetrahydropyrido[3,2-b]indolizin-6-yl]acetic acid
11/17/2009US7618975 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis; antiproliferative, anticarcinogenic, antimetabolic agents; tubulin and topoisomerase II inhibitors; fungicides; synergistic administration with other anticarcinogenic agents
11/17/2009US7618964 Benzamide derivatives, their manufacture and use as pharmaceutical agents
11/17/2009US7618963 Bicyclic heteroaromatic compounds
11/17/2009US7618959 6-({2-[4-(6-Methoxy-[1,5]naphthyridin-4-yl)phenyl]ethylamino}methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one;bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
11/17/2009CA2432181C Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
11/17/2009CA2417082C New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
11/17/2009CA2407094C Diazabicyclic central nervous system active agents
11/12/2009WO2009137681A1 Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
11/12/2009WO2009137342A1 Therapeutically useful substituted 1, 7-diphenyl-l, 2, 3, 5, 6, 7-hexahydropyrido [ 3, 2, 1-i j ] quinoline compounds
11/12/2009WO2009137201A1 Triazolopyridinone derivatives for use as stearoyl coa desaturase inhibitors
11/12/2009WO2009136814A1 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof
11/12/2009WO2009136813A1 2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidine antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof
11/12/2009WO2009136663A1 Fused heterocyclic derivatives and use thereof
11/12/2009WO2009135842A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists
11/12/2009WO2009135788A1 Heterocyclic antiviral compounds
11/12/2009WO2009135651A1 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase cyp11b2
11/12/2009WO2009117278A3 Processes for preparing (amino-pyrazolopyridinyl)methoxy substituted biaryl ethers
11/12/2009WO2009100294A3 Amide derivatives as positive allosteric modulators and methods of use thereof
11/12/2009WO2009083197A3 Asymmetric phenanthrolines, preparation process therefore and doped organic semiconductor material containing them
11/12/2009WO2009068463A9 Process for the preparation of isoindole derivatives as well as a process for the preparation of their intermediates
11/12/2009WO2009062059A3 Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors
11/12/2009WO2008121860A9 Peripheral opioid receptor antagonists and uses thereof
11/12/2009US20090281322 THERAPEUTICALLY USEFUL SUBSTITUTED 1,7-DIPHENYL-1,2,3,5,6,7-HEXAHYDROPYRIDO[3,2,1-Ij]QUINOLINE COMPOUNDS
11/12/2009US20090281313 Method for producing bicyclic guanidines by use of a cyclic urea
11/12/2009US20090281279 Rigidized trimethine cyanine dyes
11/12/2009US20090281138 Bis-(Sulfonylamino) Derivatives in Therapy 066
11/12/2009US20090281120 Bicyclic heterocyclic compound
11/12/2009US20090281115 Inhibitors of c-kit and uses thereof
11/12/2009US20090281100 Benzimidazole quinolinones and uses thereof
11/12/2009US20090281080 Spirohydantoin Tricyclic CGRP Receptor Antagonists
11/12/2009US20090281075 Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors
1 ... 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 ... 646